INS and breast carcinoma: Likewise, the prevalence of the HLA-G 14bp DEL/DEL genotype was higher in breast cancer patients than in the control group (33.9% vs 24.1%, respectively, p=0.006), suggesting that the 14bp INS/DEL polymorphism could be a genetic risk factor mediating susceptibility to breast carcinoma.